ClinVar Miner

Submissions for variant NM_000132.4(F8):c.6304G>A (p.Gly2102Ser)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Clinical Services Laboratory,Illumina RCV001169186 SCV001331854 uncertain significance Hereditary factor VIII deficiency disease 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratories RCV001169186 SCV001474163 likely pathogenic Hereditary factor VIII deficiency disease 2020-03-17 criteria provided, single submitter clinical testing The F8 c.6304G>A; p.Gly2102Ser variant (rs200433372), also known as Gly2083Ser, is reported in the literature in individuals affected with reportedly mild hemophilia A (Debeljak 2012). This variant is only observed on four alleles in the Genome Aggregation Database, indicating it is not a common polymorphism. The glycine at codon 2102 is moderately conserved, and computational analyses (SIFT: tolerated, PolyPhen-2: possibly damaging) predict conflicting effects of this variant on protein structure/function. Additionally, another variant at this codon (c.6205G>C; p.Gly2102Asp) has been reported in individuals with mild hemophilia A (Rydz 2013), and several missense variants in the same C1 domain are associated with mild hemophilia A (Green 2008, Johnsen 2017). Based on available information, the p.Gly2102Ser variant is considered to be likely pathogenic. References: Debeljak M et al. Spectrum of F8 gene mutations in haemophilia A patients from Slovenia. Haemophilia. 2012 Nov;18(6):e420-3. Green PM et al. Haemophilia A mutations in the UK: results of screening one-third of the population. Br J Haematol. 2008 Oct;143(1):115-28. Johnsen JM et al. Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative. Blood Adv. 2017 May 18;1(13):824-834. Rydz N et al. The Canadian "National Program for hemophilia mutation testing" database: a ten-year review. Am J Hematol. 2013 Dec;88(12):1030-4.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.